General Information of This Drug (ID: DM1P60V)

Drug Name
NYX-2925   DM1P60V

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diabetic neuropathy DISX6VF8 8C0Z Phase 2 [1]
Fibromyalgia DISZJDS2 MG30.01 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04146896) Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04147858) Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia. U.S. National Institutes of Health.